Spermidine is a polyamine the body produces in its own cells, and one we also get from foods like wheat germ, aged cheeses, soy products, mushrooms and certain legumes. The main reason it draws interest is that it can naturally trigger the cellular "self-cleaning" process we covered in detail in our autophagy article. Blood serum spermidine levels tend to decline with age, and that decline has led some researchers to ask whether supplementing from outside could reverse the drop.
The strongest evidence that spermidine extends lifespan comes from model organisms — yeast, worms, flies, mice. On the human side, we have two quite different kinds of data: observational studies looking at the relationship between dietary spermidine and mortality risk, and randomized trials that test supplementation directly. As you'll see, these two paint noticeably different pictures.
A 2018 study in the American Journal of Clinical Nutrition (Kiechl et al.) followed 829 people (aged 45-84) from the Bruneck region of Italy from 1995 to 2015 — a 20-year follow-up. Participants' diets were assessed with repeated questionnaires in 1995, 2000, 2005 and 2010; 341 deaths were recorded during follow-up. The result: participants with higher dietary spermidine intake had a notably lower mortality risk than those with lower intake.
This is a strong, long-running study, but it's ultimately observational: people who eat more spermidine-rich foods may also eat a generally more balanced diet overall (more vegetables, legumes, whole grains), and some of the mortality reduction could stem from that broader diet quality rather than spermidine itself. The study shows an association, not proof that spermidine alone is the cause.
A 2012 study in Rejuvenation Research (Pucciarelli et al.) compared whole-blood polyamine levels across three age groups, 78 people total (26 per group). The findings are a bit more nuanced than you'd expect: total polyamine levels decline with age, but in the oldest group (90-plus and centenarians), the proportion of spermine relative to total polyamines was notably higher than in the other groups. The researchers attribute most of that overall decline to falling levels of putrescine, a different polyamine.
An important distinction here: spermidine and spermine are related but different polyamines. This study doesn't say "centenarians have more spermidine" — it says "among the polyamines centenarians have left, a higher share is spermine." Conflating the two is a common oversimplification in this space.
This is where things slow down. A 2023 randomized, placebo-controlled crossover trial in Nutrients (Senekowitsch et al.) gave 12 healthy adults 15 mg of oral spermidine daily for 5 days (with a 9-day washout between two 5-day phases). The result is surprising: compared with placebo, that dose of spermidine did not change plasma spermidine levels at all. Instead, plasma spermine rose, while salivary polyamine levels showed no change.
The researchers suggest this happens because the spermidine consumed gets converted to spermine before it reaches systemic circulation. The practical implication: the expectation that "take a spermidine pill, and your blood spermidine goes up" wasn't confirmed, at least at this dose in this study. That doesn't directly contradict the Bruneck findings on dietary intake and mortality — one is long-term intake from real food, the other is a short-term, isolated supplement.
The most comprehensive human study testing spermidine's cognitive effects is SmartAge, published in 2022 in JAMA Network Open (Wirth et al.). Run between 2017 and 2020, this 12-month, double-masked, placebo-controlled phase 2b trial randomized 100 adults aged 60-90 with subjective cognitive decline to either a wheat-germ spermidine supplement (0.9 mg/day) or a placebo (microcrystalline cellulose).
The authors' own conclusion is clear: 12 months of low-dose (0.9 mg/day) spermidine supplementation did not change memory or the measured biomarkers relative to placebo in older adults with subjective cognitive decline. Some secondary sources report a temporary memory advantage at the 3-month mark that disappeared by month 12; the researchers suggest this may point to an inadequate dose.
A 2024 international study in Nature Cell Biology proposed that part of fasting's effects is linked to a rise in the body's spermidine levels, with that increase triggering autophagy through a process called hypusination of the eIF5A protein. The study's human data comes from samples of 109 participants drawn from a detox program and a long-term fasting study; polyamine levels were consistently observed to rise during fasting. This adds a molecular explanation to the fasting-autophagy connection we touch on in our circadian eating article.
One important caveat: this human data is observational — it shows that polyamine levels rise during fasting, not that this extends lifespan. The authors note the pathway is conserved across different species, but long-term outcomes in humans haven't been tested yet.
The honest answer with the data we have: there's reasonable observational evidence that getting spermidine from real food, long-term, may be beneficial, but no direct evidence that an isolated supplement delivers the same benefit. In fact, the one randomized pharmacokinetic trial we have found that a low-to-moderate supplement dose didn't even raise blood spermidine; the SmartAge trial found that 12 months at a low dose produced no measurable difference in memory either.
That doesn't mean spermidine "doesn't work" — the animal data is real, the proposed mechanism (triggering autophagy) is plausible, and the diet data is encouraging. But right now, the most solid recommendation is to get spermidine regularly from natural sources — wheat germ, aged cheese, soy, mushrooms, legumes — and wait for isolated supplements to be tested at higher doses and for longer periods before expecting the same effect from a pill.
On safety, there's no finding that short-term, low-to-moderate dose supplementation (0.9 mg/day in SmartAge, 15 mg/day in the Senekowitsch trial) causes a meaningful increase in adverse effects. But we don't have enough data yet on the safety of long-term, high-dose use.
No study shows this directly in humans. Spermidine extends lifespan in model organisms like yeast, worms, flies and mice. In humans, an 829-person cohort study found that higher dietary spermidine intake was associated with lower mortality risk, but that's an observational association — it doesn't prove spermidine itself is the cause.
In a 2023 randomized, placebo-controlled trial, healthy adults who took 15 mg of oral spermidine daily for 5 days showed no change in plasma spermidine — instead, plasma spermine levels rose. The researchers think the spermidine consumed is converted to spermine in the body.
In the 12-month, 100-person SmartAge randomized controlled trial, 0.9 mg/day of wheat-germ spermidine showed no significant difference from placebo on the primary memory measure in older adults with subjective cognitive decline. Exploratory analyses found some positive signals on verbal memory and inflammation markers, but the authors say these need confirmation at a higher dose.
Wheat germ, aged cheeses, soy products, mushrooms and certain legumes are among the foods rich in spermidine. Blood serum spermidine levels tend to decline with age.
"Dietary spermidine tracked with lower mortality in a long cohort. But the one randomized supplement trial we have found that the pill, at that dose, didn't even raise blood spermidine — the gap between real food and an isolated supplement is still an open question in this field."
— Vivelong Longevity Science Team